Prevention of skeletal-related events (pathological fractures, spinal cord compression, radiation or surgery to bone, or tumor-induced hypercalcemia).
In adult patients with advanced neoplasms with bone involvement.
Zoledronic acid
Lyophilized powder for injection solution
Box with 1 vial of 4 mg lyophilizate and 1 vial (5 mL) of diluent
Each lyophilized vial contains:
Zoledronic acid 4.0 mg
Each ampoule of diluent contains:
Water for injection 5 mL
PF-46321
F014427042017
HN-M-1118-0133
01169230720
M-AR-20-00372
206801
